Total Valuation
Harbor BioSciences has a market cap or net worth of $122.70M. The enterprise value is $90.78M.
Market Cap$122.70M
Enterprise Value$90.78M
Share Statistics
Harbor BioSciences has 58,429,836 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,429,836
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Harbor BioSciences’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -14.34%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-14.34%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee211.02K
Profits Per Employee-16.93K
Employee Count944
Asset Turnover0.84
Inventory Turnover44.64
Valuation Ratios
The current PE Ratio of Harbor BioSciences is ―. Harbor BioSciences’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.45
PB Ratio0.51
Price to Fair Value0.51
Price to FCF-5.44
Price to Operating Cash Flow-3.87
PEG Ratio0.04
Income Statement
In the last 12 months, Harbor BioSciences had revenue of 199.21M and earned -15.98M in profits. Earnings per share was -0.39.
Revenue199.21M
Gross Profit-15.53M
Operating Income-36.87M
Pretax Income-19.35M
Net Income-15.98M
EBITDA10.39M
Earnings Per Share (EPS)-0.39
Cash Flow
In the last 12 months, operating cash flow was -32.14M and capital expenditures 1.48M, giving a free cash flow of -30.66M billion.
Operating Cash Flow-32.14M
Free Cash Flow-30.66M
Free Cash Flow per Share-0.52
Dividends & Yields
Harbor BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta17.02
52-Week Price Change330.00%
50-Day Moving Average1.85
200-Day Moving Average1.46
Relative Strength Index (RSI)84.35
Average Volume (3m)22.00K
Important Dates
Harbor BioSciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Harbor BioSciences as a current ratio of 4.40, with Debt / Equity ratio of 0.95%
Current Ratio4.40
Quick Ratio4.24
Debt to Market Cap0.05
Net Debt to EBITDA-0.82
Interest Coverage Ratio-2.46K
Taxes
In the past 12 months, Harbor BioSciences has paid -3.37M in taxes.
Income Tax-3.37M
Effective Tax Rate0.17
Enterprise Valuation
Harbor BioSciences EV to EBITDA ratio is 7.82, with an EV/FCF ratio of -4.92.
EV to Sales0.41
EV to EBITDA7.82
EV to Free Cash Flow-4.92
EV to Operating Cash Flow-6.76
Balance Sheet
Harbor BioSciences has $103.47M in cash and marketable securities with $1.46M in debt, giving a net cash position of $102.01M billion.
Cash & Marketable Securities$103.47M
Total Debt$1.46M
Net Cash$102.01M
Net Cash Per Share$1.75
Tangible Book Value Per Share$3.89
Margins
Gross margin is -385.35%, with operating margin of -18.51%, and net profit margin of -8.02%.
Gross Margin-385.35%
Operating Margin-18.51%
Pretax Margin-9.71%
Net Profit Margin-8.02%
EBITDA Margin5.22%
EBIT Margin-9.71%
Analyst Forecast
The average price target for Harbor BioSciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-33.34%
EPS Growth Forecast93.59%